The North America allergy diagnostics market reached USD 2 billion in 2026. The market growth is attributed to the rising prevalence of allergic diseases, advances in diagnostic technologies, and growing research activities. These trends were analysed by our Senior Researcher, Deepa Pandey, to curate this report. Her report benefits device manufacturers, clinical laboratories & reference labs, CROs, digital health startups, and medical distributors.